VC Directory

VCs in Netherlands Directory

Curated index of active venture capital funds investing in Europe and Israel. Track partners, stages, and check sizes.

Triple Jump

Amsterdam, NL

Triple Jump invests in emerging markets to drive sustainable growth while creating positive social and environmental change. Their focus areas—financial inclusion, SMEs, affordable housing, clean energy, and climate/nature—align with responsible financial sector development.

Missing middle finance (financing SMEs), early-stage to growth-stage investments in emerging economies.Impact investing in emerging markets with private debtequity

UNIIQ

Rotterdam, NL
U

UNIIQ invests in research-driven startups with complex technology, often originating from academic institutions, focusing on life sciences, deeptech, and hightech. It provides capital and intensive mentorship to accelerate market introduction, with a strong emphasis on enabling follow-on financing (80%+ of portfolio companies secure follow-on funding within 3 years).

Pre-seed/seed stageEarly-stage innovationconvertible loans

University of Twente

Enschede, NL

Based on the provided website content, it is challenging to define a specific investment thesis or strategy for the University of Twente. The University of Twente is a research university in Enschede, Netherlands. The university's primary focus is on education and research in areas such as engineering, natural sciences, and social sciences. The website highlights various degree programs, research institutes, and collaboration opportunities, indicating an interest in fostering innovation and development in these fields. However, the information does not explicitly state a venture capital investment thesis or detail specific investment strategies. While the university facilitates research and offers collaboration opportunities with businesses, it does not directly present itself as a venture capital firm. The website showcases research institutes and encourages collaborations with external partners. These activities might lead to the development of technologies or startups that could be of interest to venture capitalists, but the university itself is not presented as an investment vehicle. The university's engagement with external parties through collaborations and research support suggests a potential interest in commercializing research outcomes. However, the website lacks specific details about investment criteria, target sectors, or financial instruments. Therefore, it is difficult to determine their investment approach without additional information.

Pre-Seed, Seed, Series A

Unknown Group

NL

Fueling founders to solve the world’s biggest problems by building Europe’s largest impact campus, connecting founders to industry leaders through labs, and creating Europe’s leading university for entrepreneurship.

Not explicitly mentioned, likely early stage given focus on startup competitions and university programsBacking founders solving real-world challenges in impact-driven sectors (e.g.water

Utrecht Health Seed Fund

Utrecht, NL

Utrecht Holdings Seed Fund (UHSF) invests in science-based startups originating from or closely linked to Utrecht University (UU) and University Medical Centre Utrecht (UMCU). The fund builds upon the success of the UtrechtHealthSeed Fund (UHSF I). Their primary aim is to translate scientific research into broader societal impact by providing early-stage funding to innovative companies. They are committed to supporting ventures that address pressing challenges in healthcare and sustainability, with a focus on creating impactful solutions leveraging cutting-edge research and technologies from UU and UMCU. The fund's investment strategy reflects the research strengths of its investors, primarily focusing on Life Sciences/MedTech, Digital Innovation, and Sustainability. UHSF seeks to bridge the gap between academic research and commercial application by providing crucial seed funding to spin-offs and startups that have demonstrated a clear potential for scalability and positive impact. They are actively looking for opportunities where the innovations are deeply rooted in scientific breakthroughs. The fund invests in companies located in the Netherlands, particularly those connected to the Utrecht ecosystem. They are especially interested in innovations coming from and linked to Utrecht University and University Medical Center Utrecht. The firm intends to foster an environment where early-stage ventures can thrive by providing not only financial backing but also leveraging the vast network, knowledge base, and infrastructure of Utrecht Holdings, Utrecht University and UMCU. The goal is to advance translational science, fostering the growth of innovative businesses and contributing to economic development in the region. UHSF is managed by Utrecht Holdings, the Knowledge Transfer Office of the UU and UMCU, further cementing the alignment with the strategic research priorities and ensuring a close relationship with the source of innovative technologies. The fund seeks to create an ecosystem where academic research can be translated into tangible benefits for society and is actively involved in nurturing and mentoring companies in the early stages. They operate with a collaborative mindset, partnering with other investors and stakeholders to maximize the chances of success for their portfolio companies.

SeedLife Sciences/MedTechDigital Innovation

Utrecht Holdings

Utrecht, NL

Utrecht Holdings supports researchers from Utrecht University and UMC Utrecht in translating academic inventions into real-world applications, providing legal, strategic, and financial support to bridge the gap between research and commercialization.

Seed to early-stageAcademic research commercializationearly-stage healthcare and biotech startups

VMN media

NL

VMN media is the leading B2B media company in the Netherlands, providing specialized news, knowledge, and networking opportunities across 35 sectors to empower professionals and drive informed decision-making.

Early StageHRZorg

VP Capital

Tilburg, NL

VP Capital invests in solutions addressing 3 focus challenges and 6 key solutions to accelerate sustainable progress for the planet and society. Investor additionality, potential impact, and realized impact are central to their decision-making process.

Growth stage investments, ventures, private equity, real estate, publicly traded businessesPositive impact and sustainable progress

Value Creation Capital

Bilthoven, NL

Value Creation Capital (VCC) is a venture capital firm that focuses on building great technology companies, acting as an investing entrepreneur in the Deep Tech sector since 2005. They operate as hands-on investors, leveraging a wide network of technology experts to support their portfolio companies. VCC targets Deep Tech companies operating in B2B markets, investing in both start-ups and scale-ups. They provide seed capital and Series A funding to ambitious companies, primarily focusing on those located in and around the Netherlands for start-ups and Western Europe for scale-ups. VCC's investments are centered around key enabling technologies such as Optics & Photonics, Nano technology, Robotics, Extended Reality, Advanced sensing, and AI software. These technologies are applied to address significant societal themes including Healthy Life, Energy and Materials reduction, and Security & Safety. The firm's investment strategy revolves around partnering with companies that have the potential to create a significant impact on society through technology. Their portfolio highlights a successful track record of investing in over 40 tech companies with a focus on AI software and High-Tech since 2005.

Seed, Series AMedical devices and analysisIndustry 5.0

Value Factory

NL

Value Factory Ventures invests in early-stage startups driving impact in AgriTech, FoodTech, and Sustainable Building. The firm focuses on deeptech solutions—such as regenerative agriculture, biobased construction materials, and climate-positive innovations—that address urgent global challenges like food security, climate change, and circularity. With hands-on support, expertise, and a strong network, Value Factory accelerates startups toward scalability and commercial viability.

Early stage (pre-seed and seed)Climate impactfood security

Volve Capital

Amsterdam, NL

Volve Capital invests in digital-first companies and provides capital and operational support to founding teams.

Pre-seed, Seed, and First professional investorDigital-first companies disrupting industrieswith operational support and operational partners in data

Voordegroei

NL

Voordegroei financiert Nederlandse MKB-ondernemers met snelle, persoonlijke en directe financieringsoplossingen. Met een focus op executiekracht, duurzaamheid en innovatie, biedt het team maatwerkfinanciering met korte doorlooptijden en heldere voorwaarden om groei en overnames mogelijk te maken. Het werkt samen met strategische investeerders en institutionele partijen zoals De Goudse en het Europees Investeringsfonds (EIF).

Groeifase en overnamefinanciering (MKB-ondernemingen)Financiering voor Nederlandse MKB-ondernemers bij overnamesbedrijfsmatig vastgoed en groei met focus op duurzaamheid en innovatie.

Vrederijk Investments

NL
V

Vrederijk Investments invests in and advises growth companies, primarily in the Netherlands, with an emphasis on distinctive products, technologies or services.

Waterland

Bussum, NL

Waterland partners with ambitious entrepreneurs to strengthen their competitive position and drive sustainable growth through tailored buy-and-build strategies, combining hands-on collaboration with efficiency and responsibility.

Growth-stage investmentsBuilding resilient companies through buy-and-build strategies in Europe and globally

Act-Vc

Amsterdam, NL

ACT Venture Partners invests in science-led, IP-rich technologies across AI, quantum, health, sustainability, space, and dual-use sectors, backing founders with technical depth and a mission-driven approach.

Pre-product, pre-traction, and pre-market validationEarly-stage technology ventures combining deep technical expertise with transformative vision

BGV (BioGeneration Ventures)

Naarden, NL

BioGeneration Ventures specializes in seed-stage investments for innovative early-stage life sciences companies. Leveraging deep industry experience from pharma and biotech, the firm accelerates product development and shapes portfolio companies into attractive investment opportunities by providing hands-on operational and management expertise.

SeedSeed-stage biotech and life sciences companies developing disruptive solutions for high unmet medical needs

Brightlands Venture Partners

Geleen, NL

Brightlands Venture Partners (BVP) invests in innovative companies tackling global structural challenges across health, agrifood, and renewable chemistry systems. Rooted at the intersection of research, industry, and entrepreneurship, BVP partners with founders to turn technological breakthroughs into enduring companies.

Breakthrough technologies strengthening essential societal systems (healthagrifood

Climate-KIC

Amsterdam, NL

Climate KIC is Europe’s leading climate innovation agency focused on accelerating climate action through innovation, bridging the gap between climate commitments and real-world implementation. It operates as a non-profit foundation, driving projects and programs that foster collaborative efforts to mitigate and adapt to climate change.

Idea or Patent, Prototype, Early Revenue, ScalingClimate innovationsustainability

Exor Ventures

Amsterdam, NL

Exor's primary strategy appears to be building and managing great companies for the long term. They focus on creating value through active ownership and strategic management of their portfolio companies. They look for established businesses with strong market positions and growth potential, rather than solely focusing on early-stage ventures, although they do engage in some early-stage activities through affiliated entities. Their letter to shareholders emphasizes a commitment to growth and working with exceptional people. The core focus seems to be on increasing Net Asset Value (NAV) and outperforming the MSCI World Index over time. They directly invest into mature companies that are already established in their respective markets. Exor holds significant equity stakes and voting rights in a diverse portfolio of global companies. Their involvement spans various industries, including automotive (Ferrari, Stellantis, CNH, Iveco Group), healthcare (Philips, Institut Mérieux), sports (Juventus Football Club), and technology (Via Transportation). The level of economic and voting rights varies across these investments, suggesting a tailored approach to governance and influence. Exor also founded Lingotto in 2023, a long-term investment management company, and John Elkann is also a trustee of MoMA showing investment and involvement in culture. They approach investments with a long-term perspective, emphasizing sustainable growth and value creation. This is evident in their involvement with established brands like Ferrari and Philips. While they mention an "investment approach" and a detailed checklist of financial and business issues, the specific criteria for new company investments are not explicitly detailed on the website, suggesting a case-by-case evaluation process.

Primarily late-stage (established companies), some early-stage through Vento and Thrive CapitalAutomotiveHealthcare

Forbion

Amsterdam, NL

Forbion invests in transformative biotech and sustainable solutions that drive positive societal and environmental impact while delivering financial returns. Their focus spans human health (drug development) and planetary health (food, agriculture, materials, and environmental tech). The firm emphasizes ESG principles, patient impact, and societal benefits across 11 funds managing €5bn+.

All stages of (bio-)pharmaceutical drug development, seed to growth stages (via joint venture BGV for Benelux/Germany).Groundbreaking biotech innovations and sustainable solutions improving human and planetary healthincluding drug development

Future Food Fund

Utrecht, NL

Investing in early-stage companies in Western Europe that transform the food & agriculture value chain through sustainable farming, resilient supply chains, and sustainable food development.

Early-stageSustainable food & agriculture innovation

Gilde Healthcare

Utrecht, NL

Invests in solutions for tomorrow’s world, focusing on businesses that enable better healthcare at lower cost and address planetary challenges like energy transition, biodiversity, and waste/pollution.

Venture (early-stage growth), Private Equity (lower mid-market)Healthtechtherapeutics

Holland Capital

Amsterdam, NL

Holland Capital supports ambitious founders in scaling companies and invests in products and technologies that improve customer efficiency, productivity, or strategic enablement, including technology and healthcare.

Venture, Growth, Buy-OutIT servicesspecialized consultancies

Icos Capital

Amsterdam, NL

Icos Capital focuses on accelerating decarbonization by connecting high-growth climate tech innovators with corporate expertise in growth financing, engineering, production, infrastructure, and market access. The firm leverages a Collaborative Venturing Platform to facilitate partnerships that drive scalable solutions for net-zero targets.

Not explicitly mentioned, but likely early to mid-stage given the focus on venture capital and growth financing.Fast-growing climate technology innovators and sector-leading corporations through a Collaborative Venturing Platform